Increased IDO1 expression was mainly observed in the intestinal GC subtype, with an overexpression (>3) in 50% of the cases, along with a less advanced stage characterized by an absence of lymphatic invasion (p = 0.004) and lower TNM (p = 0.02)]. Here, IDO1 is linked to gastric cancer.